EUVIMEDEUVIMED entdecken
Open Access

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023

Konstantin Andreev iD, Jeremy C Jones iD, Patrick Seiler, Ahmed Kandeil, Jasmine C M Turner, Subrata Barman, Adam M Rubrum, Richard J Webby, Elena A Govorkova iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Konstantin Andreev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, Tennessee. Hauptthemen laut MEDLINE: Antiviral Agents, Influenza A Virus, H5N1 Subtype, Neuraminidase, Drug Resistance, Viral. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antiviral susceptibility of currently circulating (2022–2023) highly pathogenic avian influenza (HPAI) A(H5N1) viruses was assessed by genotypic and phenotypic approaches. The frequency was low for neuraminidase (NA) and polymerase acidic (PA) substitutions associated with reduced inhibition by NA inhibitors (21/2698, 0.78%) or the PA inhibitor baloxavir (14/2600, 0.54%). Phenotypic testing of 22 clade 2.3.2.1a and 2.3.4.4b viruses revealed broad susceptibility to NA inhibitors and baloxavir for a conclusion that most contemporary HPAI A(H5N1) viruses retain susceptibility to antiviral drugs. Novel NA-K432E and NA-T438I substitutions (N2 numbering) were identified at elevated frequencies (104/2698, 3.85%) and caused reduced zanamivir and peramivir inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsInfluenza A Virus, H5N1 SubtypeNeuraminidaseDrug Resistance, ViralInfluenza in BirdsTriazinesAnimalsHumansAcids, CarbocyclicDibenzothiepinsMorpholinesPyridonesGuanidinesBirdsInfluenza, HumanZanamivirViral ProteinsRNA-Dependent RNA PolymeraseCyclopentanesGenotypeMicrobial Sensitivity Tests

Stichwörter der Autor:innen

H5N1avian influenzabaloxavirneuraminidase inhibitorsresistance

Substanzen

Antiviral AgentsNeuraminidaseTriazinesperamivirbaloxavirAcids, CarbocyclicDibenzothiepinsMorpholinesPyridonesGuanidines

Autor:innen und Institutionen

  • Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, Tennessee.

ORCID-Profile: Konstantin Andreev, Jeremy C Jones, Elena A Govorkova

Förderung

  • NIAID NIH HHS
  • HHS
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Department of Health and Human Services

Zitieren

APA

Andreev, K., Jones, J. C., Seiler, P., Kandeil, A., Turner, J. C. M., Barman, S., Rubrum, A. M., Webby, R. J., & Govorkova, E. A. (2024). Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad418

Vancouver

Andreev K, Jones JC, Seiler P, Kandeil A, Turner JCM, Barman S, et al. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad418

BibTeX
@article{Andreev2024,
  author = {Andreev, Konstantin and Jones, Jeremy C and Seiler, Patrick and Kandeil, Ahmed and Turner, Jasmine C M and Barman, Subrata and Rubrum, Adam M and Webby, Richard J and Govorkova, Elena A},
  title = {Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad418}
}
Kostenlos starten →